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TO THE EDITOR
Human plasmacytoid dendritic cells
(pDCs) are a subset of leukocytes able
to produce large amounts of IFN-a/b
and to differentiate into mature dendri-
tic cells in response to viruses (Cella
et al., 1999; Siegal et al., 1999). These
cells have been identified in the blood,
in inflamed secondary lymphoid organs
(Facchetti et al., 1988a; Siegal et al.,
1999), and in different pathological
conditions of the skin (Facchetti et al.,
1988a; Jahnsen et al., 2000; Farkas
et al., 2001). pDCs can be identified
by the co-expression of CD123 and
BDCA2 molecules (Dzionek et al.,
2001). The capacity of pDCs to produce
IFN-a/b depends on the expression of
certain molecules called Toll-like re-
ceptors (Iwasaki and Medzhitov, 2004).
These are cellular sensors able to
recognize the presence of DNA and
RNA viruses. In particular, pDCs ex-
press Toll-like receptor 7, required for
recognition of RNA viruses (Diebold
et al., 2004; Lund et al., 2004), and
Toll-like receptor 9, required for re-
sponding to DNA viruses (Krug et al.,
2004). For the above features, pDCs are
considered important viral detectors
and are expected to play a crucial role
in antiviral responses (Colonna et al.,
2004). However, most of the data on
pDCs and viruses are derived from in
vitro or animal models experiments,
while in humans a few studies describe
the role of pDCs in virus-related dis-
eases (Soumelis et al., 2001; Kohrgruber
et al., 2004; Longman et al., 2005). We
investigated pDCs in skin lesions and in
the blood of a patient affected by acute
varicella infection, and we provide
evidence that pDCs may play an
important role in the innate immunity
responses to viruses in vivo.
A 23-year-old man presented with a
disseminated maculo-papular and vesi-
cular eruption. Clinically, the diagnosis
of varicella (chicken pox) was made,
later confirmed by the presence of IgM
antibodies against varicella zoster virus.
The patient was treated with systemic
acyclovir and antihistamines. At the
time of the first visit, skin and blood
samples were taken after written in-
formed consent. An additional blood
sample was obtained 3 weeks later. The
study was conducted according to
the Declaration of Helsinki Principles.
The medical ethical committee of the
University of Florence approved all
described studies.
Immunohistochemistry analysis of
varicella serial sections revealed a high
number of CD123þ cells in the dermal
infiltrate (Figure 1a and d). The vessels
showed intense dilatation and con-
tained numerous CD123þ cells (Figure
1a). Using mAb anti-BDCA2, we
observed numerous positive cells
co-localizing in the same areas of the
CD123þ cells (Figure 1b and e).
Within the lumen of the vessels, many
BDCA2þ cells appeared adherent to
the endothelial wall (Figure 1g). Mor-
phologically, pDCs exhibited a round-
ish, plasmacytoid appearance (Figure
1d and e) similar to that observed in
tonsils (Figure 1h). In normal skin, some
scattered BDCA2þ cells were also
observed within the papillary dermis
(data not shown).
To verify IFN-a/b production by
pDCs, we performed immunohisto-
chemistry using anti-MxA mAb, an
IFN-a/b-inducible intracellular protein
well established as a surrogate marker
for local type I IFN production (Fah
et al., 1995; Jahnsen et al., 2000).
Although MxA expression was not
detected in normal skin, an impressive
epidermal and dermal overexpression
was observed in varicella lesions
(Figure 1c). A high number of MxAþ
cells showed plasmacytoid morphology
and were located in the same areas
where CD123/BDCA2-expressing cells
were observed, strongly suggesting that
pDCs represented the main source of
IFN-a/b (Figure 1f).
Recently, the chemokine receptor
CXCR3 has been shown to mediate
the chemotaxis of human pDCs in
virus-induced skin lesions (Kohrgruber
et al., 2004); therefore, we stained
varicella sections with anti-CXCR3
mAb. Consistent with the previous
report, numerous clusters of CXCR3þ
cells were observed in the dermal
infiltrate, often within the vessels
(Figure 1i and j). However, expression
of CXCR3 was less strong compared to
CD123 and BDCA2 molecules, pre-
sumably because pDCs rapidly down-
regulate CXCR3 upon exposure to
viruses (Kohrgruber et al., 2004).
In systemic lupus erythematosus,
pDCs accumulate in the skin lesions
whereas the number of blood pDCs is
decreased (Cederblad et al., 1998;
Farkas et al., 2001). Similarly, in the
acute phase of varicella infection, flow
cytometry analysis showed that blood
BDCA2/CD123þ pDCs were barely
detectable (0.01% of the total peri-
pheral blood mononuclear cells), in
contrast to pDCs of healthy donors
(mean7standard deviation: 0.48%7
0.13; N¼4) (data not shown). Blood
examination performed in the patient
3 weeks later showed a considerable
increase in the percentage of pDCs
(0.68%).
The data presented herein, although
limited to a single case, are consistent
with the hypothesis that pDCs play an
important role in viral skin infections in
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humans, and particularly in the early
antiviral responses. Indeed, the patient
was observed during an early phase
of the varicella eruption when pDC
traffic into virally infected sites is
expected to be maximal (Kohrgruber
et al., 2004). The finding of a high
number of CXCR3þ pDC in the dermal
infiltrate suggests that these cells might
be very rapidly recruited from the blood
to the site of virus replication where
CXCR3 ligands are strongly produced
(Kohrgruber et al., 2004). Consistently,
pDC were barely detected in peripheral
blood during the acute infection as
opposed to healthy individuals. This
hypothesis is also supported by the
high number of BDCA2-expressing
cells observed within the lumen of
the vessels and adherent to the endo-
thelial wall, presumably going to
enter the dermis. However, the low
number of blood pDC observed may
also reflect an immunosuppressive
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Figure 1. Plasmacytoid dendritic cells infiltrate varicella skin lesions and produce IFN-a/b. Representative cryostat serial sections of a varicella skin lesion were
stained with anti-CD123, anti-BDCA2, anti-MxA, and anti-CXCR3 antibodies according to the alkaline phosphatase antialkaline phosphatase technique.
The biopsy was performed at the edge of a recently developed vesicle. Samples of normal human skin from the cryomaterial archive of the Department of
Dermatological Sciences of Florence were used as negative controls. Tonsils were used as positive control for BDCA2þ pDC. (a, d) Numerous cells, in the
dermal infiltrate and within dilated vessels, are strongly stained by the monoclonal antibody against CD123, which also stains endothelial cells indicated by the
arrows (a). At higher magnification, most of the CD123-positive cells exhibit a roundish shape (d). (b, e, g) A high number of cells stained positive for the BDCA2
molecule. BDCA2 expressing cells co-localize in the same areas of CD123-positive cells in the dermal infiltrate and within the vessels (b, e). BDCA2-expressing
cells show a typical plasmacytoid morphology (e) and are found in large numbers within the vessels often adherent to the endothelial wall as indicated by the
arrows (g). (c, f) Intense IFN-a/b activity is shown in varicella lesion by staining with an antibody against MxA. (h) Sections of tonsils were used as control for
BDCA2. (i, j) Numerous CXCR3-expressing cells are shown in the dermal infiltrate often within the vessels. (k) Varicella section stained with an irrelevant anti-
idiotype antibody for negative control. Bars¼ 100mM (a, b, c, i, k), 30mM (d, e, f, g, h, j).
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condition, although transient, as de-
scribed in HIV patients (Soumelis et al.,
2001).
A crucial point is that pDCs were
functionally active in situ as shown
by the massive MxA expression in
the skin lesion. IFN-a/b secreted by
pDCs in situ activate natural killer
cell activity and, at the same time,
protect uninfected cells from natural
killer cell-mediated lysis, thus limit-
ing virus replication (Trinchieri et al.,
1978).
In conclusion, we have shown in a
case report form that pDCs promptly
infiltrate varicella skin lesions and are
able to produce IFN-a/b in vivo.
Although these findings need to be
extended to a larger number of cases,
they represent direct evidence of the
importance of pDCs in the early anti-
viral immune response.
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